Feasibility Study Focusing on Fit of Made-to-measure Compression Garments in Healthy Subjects
Explorative, Monocentric, Feasibility Study Focusing on Fit of Innovative, Made-to-measure Compression Garments in Healthy Subjects
1 other identifier
interventional
36
1 country
1
Brief Summary
Fit of made-to-measure compression garments in healthy subjects will be tested on one day, simulating daily activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2019
CompletedStudy Start
First participant enrolled
November 28, 2019
CompletedFirst Posted
Study publicly available on registry
November 29, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2019
CompletedJanuary 18, 2020
January 1, 2020
15 days
November 26, 2019
January 14, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the fit of the investigational device
Evaluation of the fit of the investigational medical device at the end of a wearing period of approximately 4 - 7 hours by predefined criteria, to be worn by healthy subjects once.
One day
Study Arms (1)
Fit test of made-to-measure garments
OTHERHealthy subjects will test maximum 2 compression garments out of 6 garments under investigation
Interventions
Made-to-measure compression garment
Eligibility Criteria
You may qualify if:
- Men, women or diverse
- Full legal competence
- Age between 18 and 70 years
- Capability to understand the subject information and to provide conscious informed consent
- All female or diverse subjects of childbearing potential must either be surgically sterile (hysterectomy or tubal ligation) or agree to use a reliable method of contraception with a Pearl-Index of less than 1% per year when used consistently and correctly such as implants, injectables, combined oral contraceptives, some intra uterine devices (IUDs), sexual abstinence or vasectomized partner for at least 4 weeks
- Willingness to conduct a urine pregnancy test for all females or potentially childbearing diverse subjects
- Capability and willingness to follow protocol requirements
- Signed informed consent for study participation and data protection regulations
- Body mass index (BMI) \>23 kg/m² and ≤ 40 kg/m²
You may not qualify if:
- Circumference of the largest circumference of the upper leg \>80 cm (measured in the upright position)
- Shape distortions
- Diagnosed lymphedema of the upper and/or lower extremities
- Diagnosed lipedema of upper and/or lower extremities
- Diagnosed indication for therapy with flat-knitted compression garments
- Alcohol abuse as reported by subject and/ or suspected by investigator
- Drug abuse as reported by subject and/ or suspected by investigator
- Allergy or sensitivity to one or more components of the investigational devices, as far as reported by the subject
- Circumference of the largest circumference of the upper leg \>80 cm (measured in the upright position)
- Shape distortions
- Diagnosed lymphedema of the upper and/or lower extremities
- Diagnosed lipedema of upper and/or lower extremities
- Diagnosed indication for therapy with flat-knitted compression garments
- Alcohol abuse as reported by subject and/ or suspected by investigator
- Drug abuse as reported by subject and/ or suspected by investigator
- +26 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BSN Medical GmbHlead
Study Sites (1)
bioskin GmbH
Hamburg, 20095, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Uwe Kröncke
Bioskin GmbH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2019
First Posted
November 29, 2019
Study Start
November 28, 2019
Primary Completion
December 13, 2019
Study Completion
December 13, 2019
Last Updated
January 18, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share
No IPD will be shared. Data are needed for confidential medical device development.